We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$317M
AUM Growth
+$79.3M
Cap. Flow
+$66.9M
Cap. Flow %
21.11%
Top 10 Hldgs %
43.22%
Holding
98
New
36
Increased
16
Reduced
11
Closed
29

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$9.61M
2
BHC icon
Bausch Health
BHC
+$7.76M
3
MDT icon
Medtronic
MDT
+$7.64M
4
BIIB icon
Biogen
BIIB
+$6.02M
5
VTRS icon
Viatris
VTRS
+$5.3M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$13.7M
2
AGN
Allergan plc
AGN
+$7.44M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$6.22M
4
PBYI icon
Puma Biotechnology
PBYI
+$5.9M
5
ZBH icon
Zimmer Biomet
ZBH
+$5.88M

Sector Composition

Rank Sector Weight
1 Healthcare 67.88%
2 Technology 0.31%
3 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLRN
26
DELISTED
Acceleron Pharma
XLRN
$4.75M 1.5%
150,000
-25,000
-14% -$807K
SUPN icon
27
Supernus Pharmaceuticals
SUPN
$2.81B
$4.5M 1.42%
265,000
-235,000
-47% -$3.34M
TEVA icon
28
Teva Pharmaceuticals
TEVA
$42.6B
$4.43M 1.4%
+75,000
New +$4.63M
IPCM
29
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
$4.15M 1.31%
75,000
+40,000
+114% +$2.03M
TRNX
30
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$3.75M 1.18%
150,000
– –
MDRX
31
DELISTED
Veradigm Inc. Common Stock
MDRX
$3.42M 1.08%
+250,000
New +$3.38M
ASMB icon
32
Assembly Biosciences
ASMB
$531M
$3.37M 1.06%
14,583
+2,083
+17% +$402K
IMDZ
33
DELISTED
Immune Design Corp.
IMDZ
$3.1M 0.98%
150,000
+50,000
+50% +$1.18M
ELGX
34
DELISTED
Endologix Inc
ELGX
$3.07M 0.97%
20,000
+15,000
+300% +$2.48M
PETX
35
DELISTED
Aratana Therapeutics, Inc.
PETX
$3.02M 0.95%
200,000
– –
IONS icon
36
Ionis Pharmaceuticals
IONS
$9.3B
$2.88M 0.91%
+50,000
New +$3.18M
AGIO icon
37
PUT
Agios Pharmaceuticals
AGIO
$1.98B
$2.78M 0.88%
+25,000
New +$2.69M
DBVT
38
DBV Technologies
DBVT
$891M
$2.68M 0.85%
9,000
+4,500
+100% +$1.16M
WMGI
39
DELISTED
Wright Medical Group Inc
WMGI
$2.63M 0.83%
100,000
– –
HNT
40
CALL
DELISTED
HEALTH NET INC
HNT
$2.56M 0.81%
+40,000
New +$2.39M
TTPH
41
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$2.37M 0.75%
2,500
-1,250
-33% -$1.02M
NUVA
42
DELISTED
NuVasive, Inc.
NUVA
$2.37M 0.75%
+50,000
New +$2.34M
AGTC
43
DELISTED
Applied Genetic Technologies Corporation
AGTC
$2.3M 0.73%
+150,000
New +$2.88M
RXDX
44
DELISTED
Ignyta, Inc.
RXDX
$2.26M 0.71%
+150,000
New +$1.82M
OMED
45
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$2.25M 0.71%
+100,000
New +$2.47M
ENDP
46
DELISTED
Endo International plc
ENDP
$1.99M 0.63%
25,000
-35,000
-58% -$3.02M
CLDX icon
47
Celldex Therapeutics
CLDX
$3.49B
$1.89M 0.6%
5,000
-1,667
-25% -$662K
PACB icon
48
Pacific Biosciences
PACB
$361M
$1.58M 0.5%
275,000
+125,000
+83% +$723K
EPZM
49
DELISTED
Epizyme, Inc
EPZM
$1.56M 0.49%
+65,000
New +$1.25M
KITE
50
DELISTED
Kite Pharma, Inc.
KITE
$1.52M 0.48%
+25,000
New +$1.43M
1
2
3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q2 2015 Portfolio in Review

As of Q2 2015, Iguana Healthcare Management held 98 positions worth $317M, up 33% from $238M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Iguana Healthcare Management deployed $66.9M of net new capital in Q2 2015, opening 36 new positions and adding to 16 existing holdings. Its largest new stake was Amgen: 60,000 shares worth $9.21M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 82% a quarter earlier, followed by Technology and Real Estate.

On the sell side, the largest reduction was Pfizer, an estimated $13.7M trimmed.

  • Iguana Healthcare Management's largest Q2 2015 buy was Amgen: 60,000 shares worth $9.21M.
  • Iguana Healthcare Management added most to Elevance Health in Q2 2015, an estimated $4.79M increase.
  • Iguana Healthcare Management's biggest Q2 2015 reduction was Pfizer, cutting an estimated $13.7M.
  • Iguana Healthcare Management fully exited Allergan plc in Q2 2015, selling an estimated $7.44M.
  • Iguana Healthcare Management's ten largest holdings make up 43% of its $317M portfolio in Q2 2015.
  • Iguana Healthcare Management opened 36 new positions and closed 29 in Q2 2015.
  • Iguana Healthcare Management's portfolio value rose 33% quarter-over-quarter to $317M.

Based on Iguana Healthcare Management's 13F filing for Q2 2015, filed 14 Aug 2015.